Raymond James & Associates’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $387K | Sell |
47,837
-1,995
| -4% | -$16.1K | ﹤0.01% | 3239 |
|
|
2024
Q2 | $216K | Buy |
49,832
+4,005
| +9% | +$17.3K | ﹤0.01% | 3530 |
|
|
2024
Q1 | $194K | Buy |
45,827
+3,000
| +7% | +$12.7K | ﹤0.01% | 3593 |
|
|
2023
Q4 | $161K | Buy |
42,827
+5,800
| +16% | +$21.8K | ﹤0.01% | 3534 |
|
|
2023
Q3 | $137K | Buy |
37,027
+200
| +0.5% | +$740 | ﹤0.01% | 3517 |
|
|
2023
Q2 | $146K | Buy |
36,827
+2,000
| +6% | +$7.93K | ﹤0.01% | 3512 |
|
|
2023
Q1 | $144K | Buy |
34,827
+1,200
| +4% | +$4.97K | ﹤0.01% | 3534 |
|
|
2022
Q4 | $142K | Hold |
33,627
| – | – | ﹤0.01% | 3523 |
|
|
2022
Q3 | $95K | Hold |
33,627
| – | – | ﹤0.01% | 3586 |
|
|
2022
Q2 | $135K | Hold |
33,627
| – | – | ﹤0.01% | 3584 |
|
|
2022
Q1 | $184K | Sell |
33,627
-2,599
| -7% | -$14.2K | ﹤0.01% | 3655 |
|
|
2021
Q4 | $165K | Buy |
36,226
+3,815
| +12% | +$17.4K | ﹤0.01% | 3723 |
|
|
2021
Q3 | $151K | Buy |
32,411
+11,137
| +52% | +$51.9K | ﹤0.01% | 3706 |
|
|
2021
Q2 | $146K | Sell |
21,274
-2,825
| -12% | -$19.4K | ﹤0.01% | 3721 |
|
|
2021
Q1 | $241K | Buy |
24,099
+1,899
| +9% | +$19K | ﹤0.01% | 3464 |
|
|
2020
Q4 | $165K | Hold |
22,200
| – | – | ﹤0.01% | 3419 |
|
|
2020
Q3 | $134K | Buy |
22,200
+12,087
| +120% | +$73K | ﹤0.01% | 3291 |
|
|
2020
Q2 | $64K | Sell |
10,113
-340
| -3% | -$2.15K | ﹤0.01% | 3303 |
|
|
2020
Q1 | $38K | Buy |
+10,453
| New | +$38K | ﹤0.01% | 3308 |
|